№ files_lp_4_process_1_34874
File format: docx Character count: 2206 File size: 30 KB
Clinical guidance for weight-adjusted Dalteparin administration and monitoring in haemodialysis patients to maintain circuit patency, with specified criteria for dose adjustments, contraindications, side effects, and reversal protocol.
Year: 2026
Institution: Royal Infirmary of Edinburgh
Department: Renal Directorate
Document Type: Clinical guideline
Intended Audience: Healthcare professionals in nephrology and dialysis units
Indication: Prevention of clotting in extracorporeal haemodialysis circuits
Dosage Information: Weight-based Dalteparin administration at start of dialysis
Monitoring: Anti-Xa levels at 1 and 4 hours post-administration under specific conditions
Contraindications: Systemic anticoagulation, invasive procedures within 24 hours, hypersensitivity to heparin or LMWHs, haemophilia, severe thrombocytopenia, recent cerebral haemorrhage, severe liver disease, acute peptic ulceration
Side Effects: Skin rashes, minor bruising, systemic allergic reactions, excessive bleeding, thrombocytopenia, skin necrosis, hyperkalaemia
Reversal: Protamine sulphate if severe bleeding occurs during or within 2 hours post-dialysis
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Enoxaparin to maintain patency of a haemodialysis circuit
Note: Year
Document type: Guidelines
Organ / Institution: Royal Infirmary of Edinburgh
Target audience: Healthcare professionals involved in haemodialysis
Context: Clinical guideline for the use of enoxaparin to prevent clotting in haemodialysis circuits.
Canberra Health Services Guideline Intermittent Haemodialysis
Note: Year
Organization / Institution: Canberra Health Services, Southern NSW Local Health District
Target Audience: Health professionals in Renal Network
Canberra Health Services Procedure Haemodialysis and Therapeutic Plasma Exchange for Adults
Year: 2026
Region / City: Canberra, Australia
Topic: Haemodialysis, Plasma Exchange, Medical Procedures
Document Type: Clinical Procedure
Organization / Institution: Canberra Health Services
Author: Not specified
Target Audience: Renal Nurses, Medical Staff
Effective Period: Ongoing
Approval Date: Not specified
Date of Last Revision: Not specified
Enoxaparin to maintain patency of a haemodialysis circuit
Note: Year
Document type: Guidelines
Organ / Institution: Royal Infirmary of Edinburgh
Target audience: Healthcare professionals involved in haemodialysis
Context: Clinical guideline for the use of enoxaparin to prevent clotting in haemodialysis circuits.
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF
Note: Year
Provision of Haemodialysis Services to Selected Institutions in KwaZulu-Natal Department of Health: Three-Year Contract
Year: 2026
Region / City: KwaZulu-Natal, Pietermaritzburg
Subject: Haemodialysis Services
Document Type: Bid Erratum Form
Organization: KwaZulu-Natal Department of Health
Tender Type: RFB
Bid Number: ZNB 5284/1/2025-H
Closing Date and Time: 23 February 2026, 11H00
Contact Persons: Dr Dianne Pillay, Dr LS Guruvadu, Mr Mpho Kotelo
Cost of Document: R 610.00
Payment Details: Natalia Building-Cashiers Office, 330 Langalibalele Street, Pietermaritzburg, 3201
Document Availability: 310 Jabu Ndlovu Street, Old Boys School Building, Pietermaritzburg, 3201; downloadable from Department of Health website
Category: Haemodialysis Services
Sector: Central Supply Chain Management
Advertisement Date: 20 January 2026
Topics: Dalteparin patency Haemodialysis